about
Common variants conferring risk of schizophreniaLongitudinal brain changes in early-onset psychosisMagnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future researchNonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum.Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis.Assessment of the increase in variability when combining volumetric data from different scanners.Polymorphisms of the IL-1 gene complex are associated with alcohol dependence in Spanish Caucasians: data from an association study.Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigationsReduced antioxidant defense in early onset first-episode psychosis: a case-control study.Role of serotonergic-related systems in suicidal behavior: Data from a case-control association study.Autism spectrum disorder: does neuroimaging support the DSM-5 proposal for a symptom dyad? A systematic review of functional magnetic resonance imaging and diffusion tensor imaging studies.Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia.Plasma antioxidant capacity is reduced in Asperger syndrome.The neurobiology of autism spectrum disorders.Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal studyAntioxidant defense system and family environment in adolescents with family history of psychosis.Standardized remission criteria in schizophrenia.Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challengesCognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosisPrevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.More treatment for those most in need? A foregone conclusion?Association study between obsessive-compulsive disorder and serotonergic candidate genes.Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use.Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia.The promise of biological markers for treatment response in first-episode psychosis: a systematic review.Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsMulticenter study of brain volume abnormalities in children and adolescent-onset psychosis.Managing acute exacerbations of schizophrenia: focus on quetiapine.Common variants at VRK2 and TCF4 conferring risk of schizophrenia.Cortical structural abnormalities in deficit versus nondeficit schizophreniaThe continuum of psychotic symptoms in the general population: a cross-national study.Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Clinical effectiveness of new generation antipsychotics in adolescent patients.Significance and meaning of neurological signs in schizophrenia: two decades later.Child neuropsychopharmacology: good news… the glass is half full.Progression of brain volume changes in adolescent-onset psychosisECNP consensus meeting. Bipolar depression. Nice, March 2007.
P50
Q24614376-F2A89472-83A7-4191-8033-A087A4A28206Q24643949-5CACC46F-C81B-4C84-9B49-7D0994AE476FQ28082090-7A3DF86B-DEAA-42F7-A66D-EE4E1C177922Q30543180-5A58BF2E-40BF-4342-898D-310E4F2292D1Q31123759-08D3D042-B29B-44EC-B3EA-27946FCB3781Q31139227-7DD52C72-A020-4AD6-AC43-7A84BF21AF56Q33504814-F9B21043-E54E-4F5D-BEA2-B6B05E6AFEFDQ33505008-59539AC8-F094-49CB-BFEE-2E291663811DQ33762566-53F80B48-A4D2-4AAF-A81C-6EBF68B474BFQ33820188-7F223D37-9FEF-47B4-A9A6-72E3C5D34404Q33901798-8DD2E957-EEBA-4A66-A12E-AAA242B98792Q34024228-8EDCC43C-1EA6-40BE-A0D3-C9F436645C37Q34157058-BC4F0026-EA58-49ED-8915-6C6EAD553F94Q34245403-24E621A2-8B07-4654-AE8C-DFA057516ACEQ34387811-DFF98592-A726-4743-BB6A-7865D0F99053Q34415868-F3B651B8-CFD8-47FA-9C7A-EF6A3ECF6CD9Q34479923-49ABCEFA-A8F2-49C6-BD9B-82615309658DQ34486075-3A33F879-2CA6-4482-84AB-0B153E28935FQ34565368-BB7A56E1-FFE3-47A5-B2AE-C58185191D07Q34580449-ADDCF2D4-3915-41E2-9A5B-13597CCBDBC0Q34604342-4F12071F-A39C-4126-ADDF-107ECDC740CAQ34613566-20E44A50-8188-4A7D-8942-ECC0345AAA5EQ34701136-9268CB5A-62E9-4301-AA45-4CC0D041654FQ34735163-87C3411A-436F-4DF4-92F8-4D42795BEA9AQ34830407-A30B5F23-CB05-4469-9A31-A1E01B1DEF4CQ34985997-A347131A-8FAF-402E-9B44-4D82C942B21CQ35369988-89D0CA36-D552-4931-89CE-6B8B3D0E3056Q35370011-8B81BE4A-F597-41D9-823E-93CC60703BDBQ35370032-42A886B8-20E6-476F-9B3B-25B5A6FE2C61Q35390281-E0C49994-0067-4BF5-9F9D-4327B9360552Q35771786-6DB16C6A-810D-495A-908D-B79B9AF01626Q35816788-A1148B58-0A33-42F3-AE94-08352037F53CQ35818882-E77389D6-62BC-463B-A481-4B6D0F4DA6C8Q35898756-EBB92CBE-360F-401B-B2E5-3F1DF2871E61Q35950534-CA1E2B23-FD7E-46D1-93AD-BEC380EFC514Q35968032-408FD44C-648E-4CF1-8C48-59F731456B56Q36164572-CE0600F5-F02F-46B2-8737-8F9267C35F42Q36930870-52628C52-BD0E-4758-94CA-C4228592A9A6Q37100414-DFB0BFFC-1E87-4295-8C97-CE732119E5DFQ37172336-881B060A-F9BB-4BFF-B5EF-2C6E39FD6A1D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Celso Arango
@ast
Celso Arango
@en
Celso Arango
@es
Celso Arango
@nl
Celso Arango
@sl
type
label
Celso Arango
@ast
Celso Arango
@en
Celso Arango
@es
Celso Arango
@nl
Celso Arango
@sl
prefLabel
Celso Arango
@ast
Celso Arango
@en
Celso Arango
@es
Celso Arango
@nl
Celso Arango
@sl
P1053
H-6433-2015
P106
P21
P31
P3829
P496
0000-0003-3382-4754